Soleno Therapeutics Faces Class Action Lawsuit Over Securities Violations

Soleno Therapeutics Engaged in Controversy: Class Action Lawsuit Filed

On March 23, 2026, the DJS Law Group announced a significant development for investors involved with Soleno Therapeutics, Inc. (NASDAQ: SLNO). The firm has reminded shareholders about a class action lawsuit accusing the company of serious securities law violations. This lawsuit emphasizes sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as well as Rule 10b-5 created by the U.S. Securities and Exchange Commission.

The class period for this legal battle extends from March 26, 2025, to November 4, 2025. It’s crucial for those who purchased shares in this timeframe to take note of the developments. The deadline for filing claims to participate in this class action is set for May 5, 2026.

Case Details

According to the details outlined in the complaint, Soleno Therapeutics is being charged with making false and misleading statements that significantly impacted investors. The center of the controversy lies in the Phase 3 clinical trial of the diazoxide choline extended-release tablets (DCCR). During this trial, safety concerns about DCCR were reported, which the company allegedly attempted to downplay publicly.

The implications of these actions suggest that Soleno’s communications to the public were not only misleading but fundamentally flawed. The company's statements during the class period were allegedly not reflective of the realities regarding the DCCR's commercial viability, which raised significant concerns among proprietary and institutional investors alike.

DJS Law Group encourages shareholders who sustained losses due to Soleno's purported misleading claims to contact them for further engagement in the class action. Participation in the case is feasible without needing the appointment as a lead plaintiff, making it accessible for individual shareholders aiming to recover their losses.

Why Choose DJS Law Group?

DJS Law Group is known for its commitment to augmenting investor returns through balanced counseling and assertive legal advocacy. The firm primarily focuses on securities class actions, ensuring that investors are represented effectively in legal matters concerning corporate governance and other related litigations.

Their client roster includes some of the most significant hedge funds and alternative asset managers in the investment world. The claims that this law group manages are considered valuable commodities that deserve respect, with a focus on realizing tangible results for investors.

Opportunities for Recovery

This lawsuit is poised to create an avenue for affected shareholders to recover their losses through a structured legal process. Engaging with DJS Law Group could provide critical insights into upcoming legal proceedings, equipping investors with the necessary tools to navigate the complexities of securities law violations.

If you are an investor whose financial standing has been affected by Soleno’s alleged misstatements, consider taking action now. Join DJS Law Group's case to potentially reclaim your losses and ensure that shareholder rights are robustly defended in court.

For those interested, direct inquiries can be made to David J. Schwartz at DJS Law Group, located in Eastchester, NY, via phone or email. Their dedication to investor rights in instances of corporate malpractice stands as a beacon of advocacy in challenging times for shareholders.

This class action lawsuit serves as a reminder of the critical importance of transparency in corporate communication and the intricate dynamics of the securities market. Investors must stay vigilant and proactive to protect their interests in financial engagements with publicly traded companies.